Description: Seoul Pharma Co., Ltd manufactures and distributes pharmaceutical products in South Korea and internationally. It provides Orally Disintegrating Film (ODF), a thin film that provides an alternative to orally disintegrating tablets with modifications. The company offers ODF products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V for collagen, hyaluronic acid, and vitamin C, as well as products for schizophrenia, vitamin B, and fatigue and immunity. The company was founded in 1976 and is headquartered in Seoul, South Korea.
Home Page: www.seoulpharma.com
21, Banpo-daero
Seoul,
06710
South Korea
Phone:
82 2 3470 2300
Officers
| Name | Title |
|---|---|
| Woo-Sung Hwang | Chairman and Chief Exec. Officer |
| De-Wook Kim | Managing Director |
| Kye-Soo Park | Managing Director |
| Jang-Won Yoon | Managing Director |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.8079 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 230 |